S
TPTX

SignatureFD’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

SignatureFD’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-123
Closed -$9K – 3459
2022
Q2 		$9K Sell
123
-45
-27% -$2K ﹤0.01% 2201
2022
Q1 		$5K Buy
168
+15
+10% +$504 ﹤0.01% 2541
2021
Q4 		$7K Buy
153
+109
+248% +$4.87K ﹤0.01% 2313
2021
Q3 		$3K Sell
44
-23
-34% -$1.64K ﹤0.01% 2585
2021
Q2 		$5K Buy
67
+4
+6% +$296 ﹤0.01% 2324
2021
Q1 		$6K Sell
63
-1
-2% -$119 ﹤0.01% 2105
2020
Q4 		$8K Buy
64
+7
+12% +$767 ﹤0.01% 1811
2020
Q3 		$5K Buy
57
+12
+27% +$836 ﹤0.01% 1933
2020
Q2 		$3K Hold
45
– – ﹤0.01% 2054
2020
Q1 		$2K Buy
45
+44
+4,400% +$2.34K ﹤0.01% 2034
2019
Q4 		$0 Hold
1
– – ﹤0.01% 2323
2019
Q3 		$0 Buy
+1
New +$44 ﹤0.01% 2247

SignatureFD's TPTX Position: Q3 2022 in Review

SignatureFD sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 123 shares — an estimated $9K sold.

SignatureFD first reported a position in TPTX in Q3 2019 and held it in 12 quarters. The position peaked at $9K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • SignatureFD reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • SignatureFD sold 123 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $9K.
  • SignatureFD first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
  • SignatureFD's Turning Point Therapeutics, Inc. Common Stock position peaked at $9K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on SignatureFD's 13F filing for Q3 2022, filed 8 Nov 2022.